Background: Diabetes mellitus (DM) poses a severe threat to global public health. Diabetic
nephropathy (DN) is one of the most common complications of diabetes and the leading …

A critical challenge faced by clinical nephrologists today is the escalating number of patients
developing end stage renal disease, a major proportion of which is attributed to diabetic …

Background: Diabetic nephropathy (DN) is the most common cause of end-stage renal
disease (ESRD) in the USA and worldwide, contributing to significant morbidity and mortality …

Abstract Background: Diabetic nephropathy (DN), especially type 2 diabetes, is now
increasing rapidly worldwide, also in Asian countries, and is one of the major long-term …

Genetic susceptibility has been proposed as an important factor for the development and
progression of diabetic nephropathy, and research efforts have been invested worldwide to …

The global prevalence of diabetic nephropathy is rising in parallel with the increasing
incidence of diabetes in most countries. Unfortunately, up to 40% of persons diagnosed with …

Up to 40% of patients with type 1 and type 2 diabetes will develop diabetic nephropathy
(DN), resulting in chronic kidney disease and potential organ failure. There is evidence for a …

Diabetic nephropathy is the most common cause of end-stage renal disease in the Western
world. There is evidence for a genetic susceptibility to diabetic kidney disease, but despite …

Diabetic kidney disease, or diabetic nephropathy (DN), is a major complication of diabetes
and the leading cause of end-stage renal disease (ESRD) that requires dialysis treatment or …

Diabetic nephropathy (DN) is a devastating complication of type 1 and type 2 diabetes and
leads to increased morbidity and premature mortality. Susceptibility to DN has an inherent …